Homologous Upregulation of GnRH Receptor MRNA by Continuous GnRH in Cultured Rat Pituitary Cells
Overview
Affiliations
The present study examined the effects of continuous treatment with gonadotropin-releasing hormone (GnRH) on GnRH receptor (GnRH-R) mRNA levels in dispersed cultures of rat pituitary cells. Pituitary GnRH-R mRNA levels were determined by competitive reverse transcriptase polymerase chain reaction. When pituitary cells were continuously exposed to a low dose of GnRH (0.2 nM), GnRH-R mRNA levels were transiently increased. The levels of GnRH-R mRNA were significantly increased up to 6 h and diminished to untreated levels by 24 h. Luteinizing hormone (LH) release was also increased significantly up to 12 h, maintaining similar levels in LH release thereafter. When GnRH antagonist ([D-pGlu1, D-Phe2, D-Trp3,6]-LH-RH) was added to the cultures together with GnRH (0.2 nM) for 6 h, the stimulatory effect of GnRH on GnRH-R mRNA levels and LH release was significantly diminished in a dose-related manner. In another experiment, pituitary cells were treated with various doses of GnRH (0.02-200 nM) for a relatively short (6 h) or a longer (24 h) period. When pituitary cells were exposed for 6 h, all doses of GnRH (0.02-200 nM) significantly increased GnRH-R mRNA levels in a dose-dependent manner. By contrast, continuous exposure to GnRH for 24 h was ineffective in changing pituitary GnRH-R mRNA levels at any given doses. These results indicate that the duration of GnRH treatment is critical for upregulation of GnRH-R mRNA by continuous GnRH. When pituitary cells were treated for 6 h with either a continuous mode of GnRH (0.2 nM) or an hourly pulsatile mode of GnRH (0.2 nM, 6 min/h), both treatments significantly augmented GnRH-R mRNA levels. Thus, the modes of GnRH application, if treated for a relatively short period, do not appear to make a significant difference in upregulation of GnRH-R mRNA levels. Collectively, our data provide strong evidence that continuous GnRH application is able to upregulate pituitary GnRH-R mRNA levels, if treated for a relatively short period (6 h).
Cutia C, Leverton L, Ge X, Youssef R, Raetzman L, Christian-Hinman C Exp Neurol. 2022; 355:114118.
PMID: 35597270 PMC: 10462257. DOI: 10.1016/j.expneurol.2022.114118.
Janjic M, Previde R, Fletcher P, Sherman A, Smiljanic K, Abebe D Sci Rep. 2019; 9(1):20098.
PMID: 31882740 PMC: 6934515. DOI: 10.1038/s41598-019-56480-1.
Janjic M, Stojilkovic S, Bjelobaba I Front Endocrinol (Lausanne). 2017; 8:221.
PMID: 28928715 PMC: 5591338. DOI: 10.3389/fendo.2017.00221.
The relationship between basal and regulated Gnrhr expression in rodent pituitary gonadotrophs.
Bjelobaba I, Janjic M, Tavcar J, Kucka M, Tomic M, Stojilkovic S Mol Cell Endocrinol. 2016; 437:302-311.
PMID: 27569529 PMC: 6364298. DOI: 10.1016/j.mce.2016.08.040.
Stewart M, Deng J, Stewart C, Mullen R, Wang Y, Lopez S Mol Endocrinol. 2012; 26(11):1847-56.
PMID: 22918878 PMC: 3487620. DOI: 10.1210/me.2012-1072.